Mestinon tablets 60 mg for myasthenia gravis (pyridostigmine bromide, Regonol, Kalymin)

General information on Japanese Mestinon tablets 60 mg for myasthenia gravis (pyridostigmine bromide, Regonol, Kalymin)

Package details: 100 tablets

Manufacturer: Kyowa Pharmaceutical Industry Co., Ltd., Japan

Active ingredient: pyridostigmine bromide (chemical formula C9H13BrN2O2)

Medical effect: Mestinon tablets are effective for the treatment of muscle weakness in patients with myasthenia gravis.

Contraindications and precautions: do not use for the following categories of patients:

• pregnant and breastfeeding women,
• patients with gastrointestinal or urethral obstruction,
• patients with parasympathicotonia,
• patients with bronchial asthma,
• patients with bradycardia,
• patients with peptic ulcer,
• patients with epilepsy,
• patients with Parkinsonism.

If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.

Dosage and administration of Mestinon tablets 60 mg from Japan for myasthenia gravis (pyridostigmine bromide, Regonol, Kalymin)

In general, for adults, take 1 tablet 3 times a day. The dosage can be adjusted by the consulting doctor according to age and symptoms.

How effective are Mestinon tablets 60 mg from Japan for myasthenia gravis (pyridostigmine bromide, Regonol, Kalymin)?

Mestinon tablets contain pyridostigmine bromide. It suppresses the decomposition of acetylcholine, which is a neurotransmitter, and helps muscle contraction by having the same effect as acetylcholine. Also, Mestinon tablets work as cholinesterase inhibitor, stopping the excessive activity of cholinesterase. As the result, this medicine effectively decreases muscle weakness in patient with myasthenia gravis.

Who should take Mestinon tablets 60 mg from Japan?

Mestinon tablets can be used for the elderly patients without any particular indications.  Studies showed this medicine improves reaction time on tests of memory and attention (M. R. Cook, C. Graham, A. Sastre, M. M. Gerkovich. “Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study”. Psychopharmacology (Berlin). 2002, July, 162(2):186-92). Also, Mestinon tablets can be used for children; however, the dosage should be prescribed by the consulting pediatrician.